{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:43:54Z","timestamp":1788997434465,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100018525","name":"Key Research and Development Program of Sichuan Province","doi-asserted-by":"publisher","award":["No. 2022YFS0042"],"award-info":[{"award-number":["No. 2022YFS0042"]}],"id":[{"id":"10.13039\/501100018525","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s43032-025-01847-1","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T19:18:16Z","timestamp":1747336696000},"page":"1886-1904","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Deciphering Shared Gene Signatures and Immune Infiltration Characteristics Between Gestational Diabetes Mellitus and Preeclampsia by Integrated Bioinformatics Analysis and Machine Learning"],"prefix":"10.1007","volume":"32","author":[{"given":"Yaqian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daijuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0164-1251","authenticated-orcid":false,"given":"Xiaodong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"issue":"9","key":"1847_CR1","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S2213-8587(20)30161-3","volume":"8","author":"P Saravanan","year":"2020","unstructured":"Saravanan P. Gestational diabetes: opportunities for improving maternal and child health. Lancet Diabetes Endocrinol. 2020;8(9):793\u2013800.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"1847_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-019-0098-8","volume":"5","author":"HD McIntyre","year":"2019","unstructured":"McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):47.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"1847_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11892-015-0699-x","volume":"16","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Zhang C. Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Curr Diab Rep. 2016;16(1):7.","journal-title":"Curr Diab Rep"},{"key":"1847_CR4","doi-asserted-by":"publisher","first-page":"e067946","DOI":"10.1136\/bmj-2021-067946","volume":"377","author":"W Ye","year":"2022","unstructured":"Ye W, Luo C, Huang J, Li C, Liu Z, Liu F. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2022;377:e067946.","journal-title":"BMJ"},{"key":"1847_CR5","doi-asserted-by":"publisher","first-page":"i4694","DOI":"10.1136\/bmj.i4694","volume":"354","author":"D Farrar","year":"2016","unstructured":"Farrar D, Simmonds M, Bryant M, et al. Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis. BMJ. 2016;354:i4694.","journal-title":"BMJ"},{"issue":"24","key":"1847_CR6","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa042973","volume":"352","author":"CA Crowther","year":"2005","unstructured":"Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477\u201386.","journal-title":"N Engl J Med"},{"issue":"1","key":"1847_CR7","doi-asserted-by":"publisher","first-page":"e1002488","DOI":"10.1371\/journal.pmed.1002488","volume":"15","author":"B Daly","year":"2018","unstructured":"Daly B, Toulis KA, Thomas N, et al. Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: A population-based cohort study. PLoS Med. 2018;15(1):e1002488.","journal-title":"PLoS Med"},{"issue":"12","key":"1847_CR8","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jamainternmed.2017.2790","volume":"177","author":"DK Tobias","year":"2017","unstructured":"Tobias DK, Stuart JJ, Li S, et al. Association of history of gestational diabetes with Long-term cardiovascular disease risk in a large prospective cohort of US women. JAMA Intern Med. 2017;177(12):1735\u201342.","journal-title":"JAMA Intern Med"},{"issue":"7","key":"1847_CR9","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","volume":"124","author":"S Rana","year":"2019","unstructured":"Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019;124(7):1094\u2013112.","journal-title":"Circ Res"},{"issue":"5","key":"1847_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","volume":"15","author":"EA Phipps","year":"2019","unstructured":"Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. 2019;15(5):275\u201389.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"1847_CR11","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/HYPERTENSIONAHA.116.06421","volume":"67","author":"SA Karumanchi","year":"2016","unstructured":"Karumanchi SA. Angiogenic factors in preeclampsia: from diagnosis to therapy. Hypertension. 2016;67(6):1072\u20139.","journal-title":"Hypertension"},{"issue":"1","key":"1847_CR12","first-page":"1","volume":"133","author":"ACOG Practice Bulletin No","year":"2019","unstructured":"ACOG Practice Bulletin No. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):1.","journal-title":"Obstet Gynecol"},{"key":"1847_CR13","doi-asserted-by":"publisher","first-page":"l2381","DOI":"10.1136\/bmj.l2381","volume":"366","author":"GJ Burton","year":"2019","unstructured":"Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:l2381.","journal-title":"BMJ"},{"issue":"3","key":"1847_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.earlhumdev.2011.08.004","volume":"88","author":"S Schneider","year":"2012","unstructured":"Schneider S, Freerksen N, R\u00f6hrig S, Hoeft B, Maul H. Gestational diabetes and preeclampsia\u2013similar risk factor profiles? Early Hum Dev. 2012;88(3):179\u201384.","journal-title":"Early Hum Dev"},{"key":"1847_CR15","doi-asserted-by":"crossref","unstructured":"Bigelow CA, Pereira GA, Warmsley A et al. Risk factors for new-onset late postpartum preeclampsia in women without a history of preeclampsia. Am J Obstet Gynecol. 2014;210(4):338.e331-338.e338.","DOI":"10.1016\/j.ajog.2013.11.004"},{"key":"1847_CR16","doi-asserted-by":"crossref","unstructured":"Wainstock T, Sergienko R, Sheiner E. Who is at risk for preeclampsia?? risk factors for developing initial preeclampsia? in a subsequent pregnancy. J Clin Med. 2020;9(4).","DOI":"10.3390\/jcm9041103"},{"issue":"5","key":"1847_CR17","doi-asserted-by":"publisher","first-page":"e0178150","DOI":"10.1371\/journal.pone.0178150","volume":"12","author":"J Lee","year":"2017","unstructured":"Lee J, Ouh Y-T, Ahn KH, et al. Preeclampsia: A risk factor for gestational diabetes mellitus in subsequent pregnancy. PLoS ONE. 2017;12(5):e0178150.","journal-title":"PLoS ONE"},{"key":"1847_CR18","doi-asserted-by":"publisher","first-page":"5581570","DOI":"10.1155\/2021\/5581570","volume":"2021","author":"WN Phoswa","year":"2021","unstructured":"Phoswa WN, Khaliq OP. The role of oxidative stress in hypertensive disorders of pregnancy (Preeclampsia, gestational Hypertension) and metabolic disorder of pregnancy (Gestational diabetes Mellitus). Oxid Med Cell Longev. 2021;2021:5581570.","journal-title":"Oxid Med Cell Longev"},{"key":"1847_CR19","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3389\/fendo.2020.00655","volume":"11","author":"CJ McElwain","year":"2020","unstructured":"McElwain CJ, Tuboly E, McCarthy FP, McCarthy CM. Mechanisms of endothelial dysfunction in Pre-eclampsia and gestational diabetes mellitus: windows into future cardiometabolic health?? Front Endocrinol (Lausanne). 2020;11:655.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"48","key":"1847_CR20","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.3346\/jkms.2022.37.e338","volume":"37","author":"YE Kang","year":"2022","unstructured":"Kang YE, Yi H-S, Yeo M-K, et al. Increased pro-inflammatory T cells, senescent T cells, and immune-check point molecules in the placentas of patients with gestational diabetes mellitus. J Korean Med Sci. 2022;37(48):e338.","journal-title":"J Korean Med Sci"},{"issue":"4","key":"1847_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41581-022-00670-0","volume":"19","author":"E Deer","year":"2023","unstructured":"Deer E, Herrock O, Campbell N, et al. The role of immune cells and mediators in preeclampsia. Nat Rev Nephrol. 2023;19(4):257\u201370.","journal-title":"Nat Rev Nephrol"},{"key":"1847_CR22","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jri.2020.103208","volume":"142","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Zhang X, Du N, et al. Immune checkpoint molecules on T cell subsets of pregnancies with preeclampsia and gestational diabetes mellitus. J Reprod Immunol. 2020;142:103208.","journal-title":"J Reprod Immunol"},{"issue":"11","key":"1847_CR23","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S1701-2163(15)30786-6","volume":"35","author":"KA Nerenberg","year":"2013","unstructured":"Nerenberg KA, Johnson JA, Leung B, et al. Risks of gestational diabetes and preeclampsia over the last decade in a cohort of Alberta women. J Obstet Gynaecol Can. 2013;35(11):986\u201394.","journal-title":"J Obstet Gynaecol Can"},{"issue":"3","key":"1847_CR24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0895-7061(98)00258-1","volume":"12","author":"CG Solomon","year":"1999","unstructured":"Solomon CG, Carroll JS, Okamura K, Graves SW, Seely EW. Higher cholesterol and insulin levels in pregnancy are associated with increased risk for pregnancy-induced hypertension. Am J Hypertens. 1999;12(3):276\u201382.","journal-title":"Am J Hypertens"},{"issue":"4","key":"1847_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3109\/00016349309068036","volume":"72","author":"L Suhonen","year":"1993","unstructured":"Suhonen L, Teramo K. Hypertension and pre-eclampsia in women with gestational glucose intolerance. Acta Obstet Gynecol Scand. 1993;72(4):269\u201372.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6","key":"1847_CR26","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/j.1471-0528.1989.tb03288.x","volume":"96","author":"H Gj\u00f8nnaess","year":"1989","unstructured":"Gj\u00f8nnaess H. The course and outcome of pregnancy after ovarian electrocautery in women with polycystic ovarian syndrome: the influence of body-weight. Br J Obstet Gynaecol. 1989;96(6):714\u20139.","journal-title":"Br J Obstet Gynaecol"},{"issue":"4","key":"1847_CR27","first-page":"543","volume":"94","author":"R Thadhani","year":"1999","unstructured":"Thadhani R, Stampfer MJ, Hunter DJ, Manson JE, Solomon CG, Curhan GC. High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy. Obstet Gynecol. 1999;94(4):543\u201350.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"1847_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.cytogfr.2013.05.008","volume":"24","author":"E Conti","year":"2013","unstructured":"Conti E, Zezza L, Ralli E, et al. Growth factors in preeclampsia: a vascular disease model. A failed vasodilation and angiogenic challenge from pregnancy onwards? Cytokine Growth Factor Rev. 2013;24(5):411\u201325.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"1847_CR29","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.diabres.2010.04.015","volume":"89","author":"O Karacay","year":"2010","unstructured":"Karacay O, Sepici-Dincel A, Karcaaltincaba D, et al. A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24\u201336 weeks of gestation. Diabetes Res Clin Pract. 2010;89(3):231\u20138.","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"1847_CR30","doi-asserted-by":"publisher","first-page":"e482481","DOI":"10.1016\/j.ajog.2009.05.032","volume":"201","author":"A Wiznitzer","year":"2009","unstructured":"Wiznitzer A, Mayer A, Novack V, et al. Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am J Obstet Gynecol. 2009;201(5):e482481\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1847_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41420-022-00913-w","volume":"8","author":"D Bao","year":"2022","unstructured":"Bao D, Zhuang C, Jiao Y, Yang L. The possible involvement of circrna DMNT1\/p53\/JAK\/STAT in gestational diabetes mellitus and preeclampsia. Cell Death Discov. 2022;8(1):121.","journal-title":"Cell Death Discov"},{"issue":"1","key":"1847_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10735-013-9534-3","volume":"45","author":"G Unek","year":"2014","unstructured":"Unek G, Ozmen A, Mendilcioglu I, Simsek M, Korgun ET. Immunohistochemical distribution of cell cycle proteins p27, p57, Cyclin D3, PCNA and Ki67 in normal and diabetic human placentas. J Mol Histol. 2014;45(1):21\u201334.","journal-title":"J Mol Histol"},{"issue":"3","key":"1847_CR33","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.cell.2016.05.074","volume":"166","author":"E Choi","year":"2016","unstructured":"Choi E, Zhang X, Xing C, Yu H. Mitotic checkpoint regulators control insulin signaling and metabolic homeostasis. Cell. 2016;166(3):567\u201381.","journal-title":"Cell"},{"issue":"4","key":"1847_CR34","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.cellsig.2013.01.008","volume":"25","author":"Q Huang","year":"2013","unstructured":"Huang Q, Li J, Wang F, et al. Syncytin-1 modulates placental trophoblast cell proliferation by promoting G1\/S transition. Cell Signal. 2013;25(4):1027\u201335.","journal-title":"Cell Signal"},{"issue":"6","key":"1847_CR35","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s00018-022-04294-2","volume":"79","author":"C Bu","year":"2022","unstructured":"Bu C, Wang Z, Ren Y, Chen D, Jiang S-W. Syncytin-1 nonfusogenic activities modulate inflammation and contribute to preeclampsia pathogenesis. Cell Mol Life Sci. 2022;79(6):290.","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"1847_CR36","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/cdd.2009.167","volume":"17","author":"JE Ray","year":"2010","unstructured":"Ray JE, Garcia J, Jurisicova A, Caniggia I. Mtd\/Bok takes a swing: proapoptotic Mtd\/Bok regulates trophoblast cell proliferation during human placental development and in preeclampsia. Cell Death Differ. 2010;17(5):846\u201359.","journal-title":"Cell Death Differ"},{"issue":"6","key":"1847_CR37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1530\/REP-20-0638","volume":"161","author":"H-L Song","year":"2021","unstructured":"Song H-L, Liu T-H, Wang Y-H, et al. Appropriate expression of P57kip2 drives trophoblast fusion via cell cycle arrest. Reproduction. 2021;161(6):633\u201344.","journal-title":"Reproduction"},{"key":"1847_CR38","doi-asserted-by":"publisher","first-page":"597549","DOI":"10.3389\/fendo.2020.597549","volume":"11","author":"L Duan","year":"2020","unstructured":"Duan L, Schimmelmann M, Wu Y, et al. CCN3 signaling is differently regulated in placental diseases preeclampsia and abnormally invasive placenta. Front Endocrinol (Lausanne). 2020;11:597549.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"1847_CR39","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1111\/jcmm.16499","volume":"25","author":"H Chen","year":"2021","unstructured":"Chen H, Tang X, Han T-L, et al. Potential role of FoxO3a in the regulation of trophoblast development and pregnancy complications. J Cell Mol Med. 2021;25(9):4363\u201372.","journal-title":"J Cell Mol Med"},{"key":"1847_CR40","doi-asserted-by":"crossref","unstructured":"Kreis N-N, Friemel A, Jennewein L et al. Functional analysis of p21Cip1\/CDKN1A and its family members in trophoblastic cells of the placenta and its roles in preeclampsia. Cells 2021;10(9).","DOI":"10.3390\/cells10092214"},{"key":"1847_CR41","doi-asserted-by":"crossref","unstructured":"Majali-Martinez A, Weiss-Fuchs U, Miedl H et al. Type 1 diabetes mellitus and the first trimester placenta: Hyperglycemia-Induced effects on trophoblast proliferation, cell cycle regulators, and invasion. Int J Mol Sci. 2021;22(20).","DOI":"10.3390\/ijms222010989"},{"issue":"2","key":"1847_CR42","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4239\/wjd.v6.i2.338","volume":"6","author":"MB Aires","year":"2015","unstructured":"Aires MB, Dos Santos ACV. Effects of maternal diabetes on trophoblast cells. World J Diabetes. 2015;6(2):338\u201344.","journal-title":"World J Diabetes"},{"key":"1847_CR43","doi-asserted-by":"publisher","first-page":"705852","DOI":"10.3389\/fimmu.2022.705852","volume":"13","author":"H Liu","year":"2022","unstructured":"Liu H, Liu A, Kaminga AC, McDonald J, Wen SW, Pan X. Chemokines in gestational diabetes mellitus. Front Immunol. 2022;13:705852.","journal-title":"Front Immunol"},{"issue":"9","key":"1847_CR44","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1089\/jir.2018.0061","volume":"38","author":"J Ye","year":"2018","unstructured":"Ye J, Zhu N, Sun R, et al. Metformin inhibits chemokine expression through the AMPK\/NF-\u03baB signaling pathway. J Interferon Cytokine Res. 2018;38(9):363\u20139.","journal-title":"J Interferon Cytokine Res"},{"key":"1847_CR45","doi-asserted-by":"crossref","unstructured":"McElwain CJ, McCarthy FP, McCarthy CM. Gestational diabetes mellitus and maternal immune dysregulation: what we know so Far. Int J Mol Sci. 2021;22(8).","DOI":"10.3390\/ijms22084261"},{"issue":"4","key":"1847_CR46","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bcp.2015.04.012","volume":"95","author":"DA Shah","year":"2015","unstructured":"Shah DA, Khalil RA. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia. Biochem Pharmacol. 2015;95(4):211\u201326.","journal-title":"Biochem Pharmacol"},{"key":"1847_CR47","doi-asserted-by":"crossref","unstructured":"Matias ML, Gomes VJ, Romao-Veiga M et al. Silibinin downregulates the NF-\u03baB pathway and NLRP1\/NLRP3 inflammasomes in monocytes from pregnant women with preeclampsia. Molecules. 2019;24(8).","DOI":"10.3390\/molecules24081548"},{"key":"1847_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cyto.2018.02.007","volume":"105","author":"M Rom\u00e3o-Veiga","year":"2018","unstructured":"Rom\u00e3o-Veiga M, Matias ML, Ribeiro VR, et al. Induction of systemic inflammation by hyaluronan and hsp70 in women with pre-eclampsia. Cytokine. 2018;105:23\u201331.","journal-title":"Cytokine"},{"issue":"4","key":"1847_CR49","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1067\/mob.2001.117311","volume":"185","author":"MT Gervasi","year":"2001","unstructured":"Gervasi MT, Chaiworapongsa T, Pacora P, et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol. 2001;185(4):792\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1847_CR50","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/JLB.5RU1120-787RR","volume":"111","author":"D Miller","year":"2022","unstructured":"Miller D, Motomura K, Galaz J, et al. Cellular immune responses in the pathophysiology of preeclampsia. J Leukoc Biol. 2022;111(1):237\u201360.","journal-title":"J Leukoc Biol"},{"issue":"12","key":"1847_CR51","doi-asserted-by":"publisher","first-page":"8080","DOI":"10.4049\/jimmunol.0804018","volume":"182","author":"LM Moldenhauer","year":"2009","unstructured":"Moldenhauer LM, Diener KR, Thring DM, Brown MP, Hayball JD, Robertson SA. Cross-presentation of male seminal fluid antigens elicits T cell activation to initiate the female immune response to pregnancy. J Immunol. 2009;182(12):8080\u201393.","journal-title":"J Immunol"},{"issue":"2","key":"1847_CR52","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jri.2012.01.006","volume":"93","author":"D Darmochwal-Kolarz","year":"2012","unstructured":"Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, et al. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J Reprod Immunol. 2012;93(2):75\u201381.","journal-title":"J Reprod Immunol"},{"key":"1847_CR53","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.placenta.2019.08.077","volume":"87","author":"L Wang","year":"2019","unstructured":"Wang L, Zhang Y, Qu H, et al. Reduced ELABELA expression attenuates trophoblast invasion through the PI3K\/AKT\/mTOR pathway in early onset preeclampsia. Placenta. 2019;87:38\u201345.","journal-title":"Placenta"},{"key":"1847_CR54","doi-asserted-by":"publisher","first-page":"615973","DOI":"10.3389\/fcell.2021.615973","volume":"9","author":"Y Li","year":"2021","unstructured":"Li Y, Sun X-L, Ma C-L, et al. STX2 promotes trophoblast growth, migration, and invasion through activation of the PI3K-AKT pathway in preeclampsia. Front Cell Dev Biol. 2021;9:615973.","journal-title":"Front Cell Dev Biol"},{"issue":"4 Suppl","key":"1847_CR55","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1016\/j.ajog.2015.08.042","volume":"213","author":"SJ Fisher","year":"2015","unstructured":"Fisher SJ. Why is placentation abnormal in preeclampsia? Am J Obstet Gynecol. 2015;213(4 Suppl):S115\u201322.","journal-title":"Am J Obstet Gynecol"},{"key":"1847_CR56","doi-asserted-by":"publisher","first-page":"109498","DOI":"10.1016\/j.biopha.2019.109498","volume":"120","author":"W Luo","year":"2019","unstructured":"Luo W, Ai L, Wang B-F, Zhou Y. High glucose inhibits myogenesis and induces insulin resistance by down-regulating AKT signaling. Biomed Pharmacother. 2019;120:109498.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1847_CR57","doi-asserted-by":"publisher","first-page":"16344","DOI":"10.1038\/s41598-021-95511-8","volume":"11","author":"S Sissaoui","year":"2021","unstructured":"Sissaoui S, Egginton S, Ting L, Ahmed A, Hewett PW. Hyperglycaemia up-regulates placental growth factor (PlGF) expression and secretion in endothelial cells via suppression of PI3 kinase-Akt signalling and activation of FOXO1. Sci Rep. 2021;11(1):16344.","journal-title":"Sci Rep"},{"issue":"11","key":"1847_CR58","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.1093\/nar\/gks162","volume":"40","author":"M Okuwaki","year":"2012","unstructured":"Okuwaki M, Sumi A, Hisaoka M, et al. Function of homo- and hetero-oligomers of human nucleoplasmin\/nucleophosmin family proteins NPM1, NPM2 and NPM3 during sperm chromatin remodeling. Nucleic Acids Res. 2012;40(11):4861\u201378.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"1847_CR59","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1074\/jbc.M407856200","volume":"280","author":"N Huang","year":"2005","unstructured":"Huang N, Negi S, Szebeni A, Olson MOJ. Protein NPM3 interacts with the multifunctional nucleolar protein B23\/nucleophosmin and inhibits ribosome biogenesis. J Biol Chem. 2005;280(7):5496\u2013502.","journal-title":"J Biol Chem"},{"key":"1847_CR60","doi-asserted-by":"publisher","first-page":"216498","DOI":"10.1016\/j.canlet.2023.216498","volume":"581","author":"H Wang","year":"2024","unstructured":"Wang H, Zhou Z, Zhang J, et al. Pumilio1 regulates NPM3\/NPM1 axis to promote PD-L1-mediated immune escape in gastric cancer. Cancer Lett. 2024;581:216498.","journal-title":"Cancer Lett"},{"issue":"9","key":"1847_CR61","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1101\/gad.212548.112","volume":"27","author":"CG Hubert","year":"2013","unstructured":"Hubert CG, Bradley RK, Ding Y, et al. Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A. Genes Dev. 2013;27(9):1032\u201345.","journal-title":"Genes Dev"},{"issue":"1","key":"1847_CR62","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13046-018-0736-0","volume":"37","author":"Y Yang","year":"2018","unstructured":"Yang Y, Zhu J, Zhang T, et al. PHD-finger domain protein 5A functions as a novel oncoprotein in lung adenocarcinoma. J Exp Clin Cancer Res. 2018;37(1):65.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"1847_CR63","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1158\/0008-5472.CAN-17-3514","volume":"78","author":"Y-Z Zheng","year":"2018","unstructured":"Zheng Y-Z, Xue M-Z, Shen H-J, et al. PHF5A epigenetically inhibits apoptosis to promote breast cancer progression. Cancer Res. 2018;78(12):3190\u2013206.","journal-title":"Cancer Res"},{"issue":"1","key":"1847_CR64","doi-asserted-by":"publisher","first-page":"17521","DOI":"10.1038\/s41598-023-44899-6","volume":"13","author":"N Ding","year":"2023","unstructured":"Ding N, Li M, Zhao X. PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer. Sci Rep. 2023;13(1):17521.","journal-title":"Sci Rep"},{"issue":"1","key":"1847_CR65","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1475-2867-13-43","volume":"13","author":"E Falck","year":"2013","unstructured":"Falck E, Klinga-Levan K. Expression patterns of Phf5a\/PHF5A and Gja1\/GJA1 in rat and human endometrial cancer. Cancer Cell Int. 2013;13(1):43.","journal-title":"Cancer Cell Int"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-025-01847-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-025-01847-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-025-01847-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T18:02:58Z","timestamp":1750788178000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-025-01847-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1847"],"URL":"https:\/\/doi.org\/10.1007\/s43032-025-01847-1","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"11 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GEO belongs to public databases. The patients involved in the database have obtained ethical approval. Users can download relevant data for free for research and publish relevant articles. Our study is based on opening source data, so there are no ethical issues and other conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}